Rethinking gender and drugs.
The necessity to 'do more with less' poses challenges for policy makers and service providers in the drug and alcohol field. In recent years, some services and research initiatives have been targeted at women in an effort to compensate for their previous neglect. The question now arises that such targeting is no longer appropriate since there are fewer resources, and men constitute the main population suffering drug-related harm. This review proposes other ways of considering the question that go beyond competition over scarce resources. It shows that the present attention to women is raising new questions with potential significance to men, and suggests that research and services to the whole population can be improved by paying attention to the gender of men as well as women.